Difficulty: Medium
Average Score: 85%
Practice
A client is receiving treatment with carboplatin. Which of the following findings should the nurse monitor?
Correct answer
B
Rationale
In the case of a client receiving treatment with carboplatin, the nurse should primarily monitor for ototoxicity. Carboplatin is known to cause damage to the inner ear, leading to hearing loss or other auditory problems. Monitoring for signs of ototoxicity, such as tinnitus, vertigo, or hearing loss, is crucial to prevent permanent damage and adjust the treatment plan if necessary.
Option A, hyperglycemia, is not directly associated with carboplatin use. While some chemotherapeutic agents can lead to metabolic disturbances, carboplatin is not typically linked to hyperglycemia.
Option C, hypertension, is also not a common side effect of carboplatin. Hypertension may be a concern with other medications or conditions, but it is not a primary focus when monitoring a client on carboplatin.
Option D, bradycardia, is not a typical finding associated with carboplatin. Bradycardia is more commonly linked to certain cardiac medications or conditions and is not a known side effect of carboplatin.
Educationally, understanding the side effects and monitoring parameters of chemotherapeutic agents like carboplatin is crucial for nurses caring for oncology patients. By knowing the specific adverse effects of each medication, nurses can provide safe and effective care, promptly identify complications, and collaborate with the healthcare team to optimize patient outcomes.
Option A, hyperglycemia, is not directly associated with carboplatin use. While some chemotherapeutic agents can lead to metabolic disturbances, carboplatin is not typically linked to hyperglycemia.
Option C, hypertension, is also not a common side effect of carboplatin. Hypertension may be a concern with other medications or conditions, but it is not a primary focus when monitoring a client on carboplatin.
Option D, bradycardia, is not a typical finding associated with carboplatin. Bradycardia is more commonly linked to certain cardiac medications or conditions and is not a known side effect of carboplatin.
Educationally, understanding the side effects and monitoring parameters of chemotherapeutic agents like carboplatin is crucial for nurses caring for oncology patients. By knowing the specific adverse effects of each medication, nurses can provide safe and effective care, promptly identify complications, and collaborate with the healthcare team to optimize patient outcomes.